We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Apellis is exclusively distributing injection kits with ...

Apellis Pharmaceuticals, a biotech drug company based in Waltham, Mass., recalled more than 61,000 injection needle kits after eight retinal vasculitis cases were reported. The company is pulling 12 ...

Apellis Pharmaceuticals faces safety concerns with its drug Syfovre, prompting a recommendation for 18-gauge needles, but the underlying issue is not definitively resolved. Q2 2023 earnings show ...

While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre. The safety update comes as the company ...